| Introduction : |
|
The dramatic increase in Clinical Trial activity locally and around the world calls for a
pool of highly effective Clinical Trial project managers. At present, many in the industry
recognize that there is a Critical shortage of trained professionals, especially in the
management of Clinical Trials. Professionals with MBA in Clinical Research are in great
demand in industry as they can optimize various elements of the Clinical Trial process
in order to improve quality, get to market faster and remain a player in a highly
competitive industry. The present specialization in the MBA course will provide
excellent opportunities to students.
|
|
| Objectives of the Course: |
|
This course will provide the students with a strong theoretical and practical background
in the principles of management and the fundamentals of Clinical research.
The course shall equip the students with skills to deal with management and technical
aspects in various fields of clinical research.
|
|
| Eligibility |
B.Sc., M.Sc., BPharm, MPharm, Ph.D, BDS, MBBS,
BHMS, BAMS, MD
Clearance in Entrance Test (TMU-ET), GDPI . |
| Duration |
2 Years Full time
|
| Examination Pattern |
Semester. |
| Entrance Exam Shedule |
Structure of M.Sc.Clinical Research Entrance 2009-10
Section |
Subject |
Marks |
1.
2.
3.
4.
|
English
Quantitative Aptitude
Logical Reasoning
G. K. & Business Awareness
Total
|
30
20
20
30
100 |
|
|
Duration of the Exam : 90 mins.
Total No. of Questions : 100 Questions
Nature of Questions : Multiple Choice
|
|
|
| Syllabus |
Syllabus Contents
(for 2 Years Full-time Course)
|
| Note:: Syllabus
Subject to Revision |
| Semister - I |
|
Sr. No.
|
Sub Code
|
Name of the Subject
|
Marks
|
|
1
|
MBA 101
|
Essentials and Functions of Management
|
100
|
|
2
|
MBA 102
|
Managerial Economics
|
100
|
|
3
|
MBA 103
|
Communication Skills in Business
|
100
|
|
4
|
MBA 104
|
Management Accounting
|
100
|
|
5
|
MBA 105
|
Organizational Behaviour
|
100
|
|
6
|
MBA 106
|
Quantitative Methods
|
100
|
|
7
|
MCR 101
|
Pharmacology & Drug Development
|
100
|
|
8
|
MCR 102
|
Introduction to Clinical Research
|
100
|
|
|
Total
|
800
|
|
| Semister - II |
|
Sr. No.
|
Sub Code
|
Name of the Subject
|
Marks
|
|
1
|
MBA 201
|
Human Resource Management |
100
|
|
2
|
MBA 202
|
Marketing Management |
100
|
|
3
|
MBA 203
|
Financial Management |
100
|
|
4
|
MBA 204
|
Production Operations and Materials Management |
100
|
|
5
|
MBA 205
|
Business Environment |
100
|
|
6
|
MBA 206
|
Organisational Effectiveness & Change |
100
|
|
7
|
MCR 201
|
Indian & International Regulatory Affairs |
100
|
|
8
|
MCR 202
|
Essential Document Writing |
100
|
|
|
Total
|
800
|
|
| Semister - III |
|
Sr. No.
|
Sub Code
|
Name of the Subject
|
Marks
|
|
1
|
MBA 301
|
Entrepreneurship Development |
100
|
|
2
|
MBA 302
|
Management Information System (MIS) |
100
|
|
3
|
MBA 303
|
Legal Aspects of Business
|
100
|
|
4
|
MBA 304
|
Supply Chain Management |
100
|
|
|
|
Specialization Subjects - 2 |
200
|
|
|
|
Project Work |
200
|
|
|
Total
|
800
|
Specialization Subjects (Clinical Research)
|
|
1.
|
MCR 301
|
Pharmacovigilance & Clinical Data Management |
100
|
|
2.
|
MCR 302
|
Clinical Research Project Management |
100
|
Project Work (Equivalent to 2 Subjects)
|
|
1.
|
MCR 303
|
Project Work |
100
|
|
2.
|
MCR 304
|
Project Work |
100
|
|
| Semister - IV |
|
Sr. No.
|
Sub Code
|
Name of the Subject
|
Marks
|
|
1
|
MBA 401
|
Corporate Policies and Strategic Management |
100
|
|
2
|
MBA 402
|
International Business Environment and Management |
100
|
|
|
|
* Specialization Subjects (6 Subjects)
|
600
|
|
|
Total
|
800
|
Specialization Subjects (Clinical Research)
|
|
1.
|
MCR 401
|
Herbal & Medical Devices Trials |
100
|
|
2.
|
MCR 402
|
Medical Statistics |
100
|
|
3.
|
MCR 403
|
Pharmacoeconomics |
100
|
|
4.
|
MCR 404
|
Intellectual Property Rights |
100
|
|
5.
|
MCR 405
|
Clinical Development Planning |
100
|
|
6.
|
MCR 406
|
Pharamcogenomics |
100
|
|
Course Fees |
Year
First
Second
|
Pune
75,000
70,000
|
Navi Mumbai & Mumbai
90,000
84,000
|
|
(Fees applicable for current academic year.)
|
